Screener
Champions Oncology CSBR Q3 2026 earnings
Reported September 10, 2026 · After market close
Revenue$15.2MBeat by $187.0K
EPS$0.05Beat by $0.06
Revenue estimate$15.0M
EPS estimate-$0.01
Next report
Dec 15, 2026 (in a month)Revenue estimate$16.4M
EPS estimate$0.02
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Champions Oncology report Q3 2026 earnings?
- Champions Oncology (CSBR) reported Q3 2026 earnings on September 10, 2026 after market close.
- What were Champions Oncology's Q3 2026 revenue and EPS?
- Champions Oncology reported revenue of $15.2M and eps of $0.05 for Q3 2026.
- Did Champions Oncology beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $15.0M by $187.0K. EPS beat the consensus estimate of $-0.01 by $0.06.
- How did Champions Oncology's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 8.8% from $14.0M a year earlier.
- Where can I find Champions Oncology's Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-061383) and the 10-Q periodic report (0001628280-26-061519) directly on SEC EDGAR. The filing index links above go to sec.gov.
